These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

427 related articles for article (PubMed ID: 32888223)

  • 21. Effects of psoralen-UV-A-Turban in alopecia areata.
    Broniarczyk-Dyla G; Wawrzycka-Kaflik A; Dubla-Berner M; Prusinska-Bratos M
    Skinmed; 2006; 5(2):64-8. PubMed ID: 16603835
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy and safety of anthralin in combination with diphenylcyclopropenone in the treatment of alopecia areata: a retrospective case series.
    Nasimi M; Ghandi N; Abedini R; Mirshamsi A; Shakoei S; Seirafi H
    Arch Dermatol Res; 2019 Oct; 311(8):607-613. PubMed ID: 31165933
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Higher concentrations of dithranol appear to induce hair growth even in severe alopecia areata.
    Ngwanya MR; Gray NA; Gumedze F; Ndyenga A; Khumalo NP
    Dermatol Ther; 2017 Jul; 30(4):. PubMed ID: 28598005
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Congenital alopecia areata.
    Lenane P; Pope E; Krafchik B
    J Am Acad Dermatol; 2005 Feb; 52(2 Suppl 1):8-11. PubMed ID: 15692503
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Alopecia areata and treatment].
    Stene JJ
    Rev Med Brux; 2004 Sep; 25(4):A282-5. PubMed ID: 15516057
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Real-world experience and long-term evaluation of tofacitinib in refractory alopecia areata: A prospective, open-label, single-center study in Asian Arab population.
    Husein-ElAhmed H; Abdulla N; Al-Obaidli A; Ali-Alam M; Steinhoff M
    Dermatol Ther; 2022 Dec; 35(12):e15871. PubMed ID: 36177791
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Case Report of Alopecia Areata Treated With Individualized Homoeopathy.
    Lamba P; Bhasme A; Kumar A
    Altern Ther Health Med; 2023 Nov; 29(8):478-481. PubMed ID: 37883772
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alteration in hair texture following regrowth in alopecia areata: a case report.
    Valins W; Vega J; Amini S; Woolery-Lloyd H; Schachner L
    Arch Dermatol; 2011 Nov; 147(11):1297-9. PubMed ID: 21768446
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Retrospective Review of Anthralin in Petrolatum in the Treatment of Alopecia Areata in the Pediatric Population.
    Zafrir Y; Tantuco K; Tangtatco AJA; Ho N
    J Cutan Med Surg; 2023; 27(5):449-453. PubMed ID: 37559401
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interventions for alopecia areata.
    Delamere FM; Sladden MM; Dobbins HM; Leonardi-Bee J
    Cochrane Database Syst Rev; 2008 Apr; (2):CD004413. PubMed ID: 18425901
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of adapalene in alopecia areata: Efficacy and safety of mometasone furoate 0.1% cream versus combination of mometasone furoate 0.1% cream and adapalene 0.1% gel in alopecia areata.
    Unal M
    Dermatol Ther; 2018 Jan; 31(1):. PubMed ID: 29193637
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Baricitinib as the first systemic treatment for severe alopecia areata.
    Kincaid CM; Arnold JD; Mesinkovska NA
    Expert Rev Clin Immunol; 2023 Jun; 19(6):565-573. PubMed ID: 37042112
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Normalisation of hair follicle morphology in C3H/HeJ alopecia areata mice after treatment with squaric acid dibutylester.
    Gardner S; Freyschmidt-Paul P; Hoffmann R; Sundberg JP; Happle R; Lindsey NJ; Tobin DJ
    Eur J Dermatol; 2000 Aug; 10(6):443-50. PubMed ID: 10980465
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The comparison of therapeutic effect of Clobetasol propionate lotion and squill extract in alopecia areata: a randomized, double-blind clinical trial.
    Moosavi ZB; Aliabdi M; Golfakhrabadi F; Namjoyan F
    Arch Dermatol Res; 2020 Apr; 312(3):173-178. PubMed ID: 31707498
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intravenous methylprednisolone pulse therapy in severe alopecia areata.
    Senila SC; Danescu SA; Ungureanu L; Candrea E; Cosgarea RM
    Indian J Dermatol Venereol Leprol; 2015; 81(1):95. PubMed ID: 25566921
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Etanercept does not effectively treat moderate to severe alopecia areata: an open-label study.
    Strober BE; Siu K; Alexis AF; Kim G; Washenik K; Sinha A; Shupack JL
    J Am Acad Dermatol; 2005 Jun; 52(6):1082-4. PubMed ID: 15928633
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Topical squaric acid dibutylester therapy for alopecia areata: a double-sided patient-controlled study.
    Chua SH; Goh CL; Ang CB
    Ann Acad Med Singap; 1996 Nov; 25(6):842-7. PubMed ID: 9055014
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Changing Landscape of Alopecia Areata: An Introduction.
    Han G
    Adv Ther; 2017 Jul; 34(7):1584-1585. PubMed ID: 28646391
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An Excellent Response to Tofacitinib in a Pediatric Alopecia Patient: A Case Report and Review.
    Brown L; Skopit S
    J Drugs Dermatol; 2018 Aug; 17(8):914-917. PubMed ID: 30124734
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Successful treatment of alopecia areata-like hair loss with the contact sensitizer squaric acid dibutylester (SADBE) in C3H/HeJ mice.
    Freyschmidt-Paul P; Sundberg JP; Happle R; McElwee KJ; Metz S; Boggess D; Hoffmann R
    J Invest Dermatol; 1999 Jul; 113(1):61-8. PubMed ID: 10417620
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.